Granted Patent
B2
US 9,657,061 · App. 14/400,052 · Granted May 23, 2017
Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
Assignee:
Circassia Limited
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to a hydrochloride salt of a peptide consisting of the sequence of CPAVKRDVDLFLT (SEQ ID NO: 1) as well as its combinations with other peptides for immunosuppressive purposes.
Claims (1)
1. A hydrochloride salt of a peptide consisting of the sequence of CPAVKRDVDLFLT (SEQ ID NO: 1), which is substantially free of (a) the impurity formed by cleavage of the terminal cysteine-proline residues from the peptide consisting of the sequence of SEQ ID NO: 1; and (b) the cysteine sulfinic acid form of the peptide consisting of the sequence of SEQ ID NO: 1, and (c) the dimer of the peptide consisting of the sequence of SEQ ID NO: 1.
Assignments (3)
CHANGE OF NAME
Recorded Dec 23, 2021
From: ADIGA LIFE SCIENCES LIMITED
To: VAXERNA LIMITED
Reel/Frame 058471/0346 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 23, 2021
From: CIRCASSIA LIMITED
To: ADIGA LIFE SCIENCES LIMITED
Reel/Frame 058574/0031 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 5, 2015
From: LAIDLER, PAUL; FARKAS, IMRE
To: CIRCASSIA LIMITED
Reel/Frame 034631/0645 →
Priority Claims (1)
GB 1208293.9
· May 11, 2012
· national
Continuity (1)